Antithrombotic therapy for atrial fibrillation.
نویسندگان
چکیده
Pooled estimate 1 2.5 (1.8-3.5) .59 (for heterogeneity) Studies included in pooled estimate: AFI 2/ 1994 2.5 (NR) , .05 SPAF I-III Aspirin 3/ 1999 2.9 (NR) , .001 Stöllberger et al 4 /1998 3.7 (1.5-7.5) .002 Wang et al 5 /2003 1.9 (1.1-3.3) NR Studies not included in pooled estimate: AFI Echo 6 /1998a 3.5 (1.8-6.7) , .001 Aronow et al 7 /1998 1.6 (1.1-2.2) , .009 Hart et al 8 /2000 (intermittent AF) 4.1 (NR) .01 Hart et al 8 /2000 (sustained AF) 2.7 (NR) , .001 SPAF I 9 /1992 2.1 (NR) .04 Stöllberger et al 10 /2004 2.14 (NR) .045 van Latum et al 11 /1995 1.6 (1.0-2.6) , .05 Van Staa et al 12 /2011 2.86 (2.53-3.22) , .05
منابع مشابه
Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls.
OBJECTIVE To determine whether the risk of falling (with a possible increased chance of subdural hematoma) should influence the choice of antithrombotic therapy in elderly patients with atrial fibrillation. DESIGN A Markov decision analytic model was used to determine the preferred treatment strategy (no antithrombotic therapy, long-term aspirin use, or long-term warfarin use) for patients wi...
متن کاملImproving outpatient warfarin use for hospitalized patients with atrial fibrillation
UNLABELLED Atrial fibrillation affects an estimated 5 million Americans and accounts for approximately 15% of all strokes. Few studies have successfully addressed patient screening, assessment, and introduction of appropriate antithrombotic therapy in patients with atrial fibrillation. OBJECTIVE To assess whether an intervention improved planned antithrombotic prescribing at the time of disch...
متن کاملCost-effectiveness of preference-based antithrombotic therapy for patients with nonvalvular atrial fibrillation.
BACKGROUND AND PURPOSE Recent atrial fibrillation guidelines recommend the incorporation of patient preferences into the selection of antithrombotic therapy. However, no trial has examined how incorporating such preferences would affect quality-adjusted survival or medical expenditure. We compared 10-year projections of quality-adjusted survival and medical expenditure associated with two atria...
متن کاملAntithrombotic treatment of atrial fibrillation in a regional hospital in Hong Kong.
OBJECTIVE To measure the use, appropriateness, and safety of antithrombotic therapy in Hong Kong Chinese patients with atrial fibrillation. DESIGN Retrospective review. SETTING Regional hospital, Hong Kong. SUBJECTS AND METHODS Medical records of all patients with atrial fibrillation admitted to acute internal medicine wards in April 2000 and between July and October 2001 were reviewed fo...
متن کاملNonrheumatic atrial fibrillation. Risk of stroke and role of antithrombotic therapy.
T here has been a long-standing consensus1 that the risk of embolization in patients with atrial fibrillation and rheumatic heart disease, in particular, mitral stenosis, is sufficiently high to justify anticoagulant prophylaxis. However, there has been no consensus in regard to nonrheumatic atrial fibrillation. The recognition that nonrheumatic atrial fibrillation is common and associated with...
متن کاملAntithrombotic therapy in elderly patients with non-valvular atrial fibrillation: a pilot study
OBJECTIVE Non-valvular atrial fibrillation (NVAF) is one common arrhythmia in the elderly. However, use of antithrombotic therapy in this population is not well known in the People's Republic of China. This study aimed at investigating antithrombotic therapy status in elderly patients with NVAF in our hospital. METHODS A cross-sectional study of consecutive geriatric patients aged ≥60 years w...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- BMJ
دوره 325 7371 شماره
صفحات -
تاریخ انتشار 2002